Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0002034665-25-000009

President and COO sold 12,500 shares at $18.05 ($225,588)

  • President and COO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohlhepp Ryan President and COO 2025-11-21 Option exercise 10b5-1 +8,000 $3.79 $30,318 206,141 D
Cohlhepp Ryan President and COO 2025-11-21 Sale 10b5-1 −8,000 $18.05 $144,376 198,141 D
Cohlhepp Ryan President and COO 2025-11-21 Sale 10b5-1 −4,500 $18.05 $81,212 193,641 D
Derivatives
Cohlhepp Ryan President and COO 2025-11-21 Option exercise · Stock Option (Right to Buy) 10b5-1 −8,000 149,334 D
Open-market sales · 12,500 sh · avg $18.05 · $225,588
Loading xslF345X05/wk-form4_1764114091.xml…